Search results
Author(s):
Andrew SP Sharp
,
Indranil Dasgupta
,
Felix Mahfoud
,
et al
Start date:
Dec 07, 2018
View more
Author(s):
Lisa Brandon
,
Faisal Sharif
Added:
3 years ago
Resistant hypertension remains a serious clinical burden despite significant advances in cardiology and healthcare. Hypertension is a chronic condition without any available cure, with significant associated morbidity and mortality, and necessitates lifelong use of medications. It is multifactorial in origin, associated with genetics, lifestyle factors and the metabolic syndrome. Resistant…
View more
Treating Hypertension With uRDN
Author(s):
Atul Pathak
,
Joost Daemen
,
Joachim Weil
Start date:
Mar 31, 2023
Broadcast
Author(s):
Dominik Linz
,
Felix Mahfoud
,
Sebastian Ewen
,
et al
Added:
3 years ago
The sympathetic nervous system regulates cardiac output, blood pressure (BP), heart rate and volume, electrolyte balance and composition of body fluids. The afferent signals to the brain are regulated by mechanosensitive baroreceptors, volume sensors and chemoreceptors located in the vessels and in many other organs, particularly in the heart, kidney, lung, brain and muscles. Sympathetic nervous…
View more
Author(s):
Roland Schmieder
,
Michel Burnier
,
Cara East
,
et al
Added:
1 year ago
Author(s):
David Kandzari
Added:
1 year ago
In this insightful interview, Dr David Kandzari (Piedmont Heart Institute, Atlanta, US) joins us to outline the 6-month primary findings of an extension study of the SPYRAL HTN-ON MED Trial (NCT02439775).
SPYRAL HTN aimed to determine the safety and effectiveness of Symplicity Spyral™ multi-electrode renal denervation system (Medtronic) in patients with hypertension and cardiovascular diseases…
View more
The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option
Author(s):
Justin E Davies
,
Faisal Sharif
Start date:
Oct 12, 2020
Broadcast
Stenting of Hypoplastic Aortic Segments with Mild Pressure Gradients and Arterial Hypertension
Author(s):
Derize E Boshoff
,
Werner Budts
,
Marc Gewillig
Added:
3 years ago
Article
Author(s):
Deepak L Bhatt
Added:
1 year ago
TCT 22 - Dr Deepak Bhatt (Brigham and Women's Hospital, US) joins us to discuss the findings of SYMPLICITY HTN-3 (NCT01418261), originally presented at TCT Conference 2022.
SYMPLICITY is a randomized, sham-controlled clinical trial studying the efficacy and safety of Symplicity Flex renal denervation catheter (Medtronic)for uncontrolled hypertension.
Questions:
1. What was the rationale for this…
View more
Author(s):
Ajay J Kirtane
Added:
1 year ago
TCT 22 - In this short video from TCT 2022, Dr Ajay Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, NY, US) joins us to discuss the findings of ReCor's RADIANCE II Pivotal trial, which aimed to evaluate the safety and effectiveness of the Paradise renal Denervation System in patients with stage 2 hypertension.
225 patients were randomized to receive either a renal…
View more